default author photo

Reinhard Dummer

University Hospital Zurich - Department of Dermatology

Switzerland

SCHOLARLY PAPERS

5

DOWNLOADS

325

TOTAL CITATIONS

1

Scholarly Papers (5)

1.

Resminostat for Maintenance Treatment in Patients with Advanced Stage Mycosis Fungoides or Sézary Syndrome: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial

Number of pages: 29 Posted: 12 Jun 2024
Johannes Gutenberg University Mainz - University Medical Center, University of Turin, KU Leuven - University Hospitals Leuven, University Hospital Zurich - Department of Dermatology, University of Göttingen, University of Göttingen, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Centre Hospitalier Universitaire Vaudois (CHUV), Niigata University - Division of Dermatology, The Christie NHS Foundation Trust, San Gallicano Dermatological Institute IRCCS, Université Paris Cité, Centre Hospitalier Lyon-Sud - Hospices Civils de Lyon, Tohoku University, St John's Institute of Dermatology, Ruhr University of Bochum, Schleswig-Holstein University, University of Lubeck, Kantonsspital St Gallen, Ludwigshafen Medical Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Maria Curie-Sklodowska University, University of Lodz, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Consorcio Mar Parque de Salud de Barcelona, University Hospital Zurich - Department of Dermatology, UZ Leuven Hospitals - epartment of General Medical Oncolog, Yakut Hinsah Co. Ltd, Medical University of Vienna, Johannes Gutenberg University Mainz - University Medical Center, University Hospitals Birmingham NHS Foundation Trust and Independent
Downloads 116 (613,149)
Citation 1

Abstract:

Loading...

cutaneous t cell lymphoma, maintenance treatment, resminostat, HDAC inhibitor

2.

Combination of the Novel Raf Dimer Inhibitor Brimarafenib with the Mek Inhibitor Mirdametinib is Effective Against Nras Mutant Melanoma

Number of pages: 45 Posted: 09 Sep 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Zurich, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Hospital Zurich - Department of Dermatology, University Hospital Zurich - Department of Dermatology and affiliation not provided to SSRN
Downloads 97 (704,534)

Abstract:

Loading...

Metastatic melanomaRAF dimer inhibitorMAPK pathwaydual inhibitionNRAS mutation

3.

Oncolytic Virotherapy Mediated Anti-Tumor Response: A Single-Cell Perspective

Number of pages: 35 Posted: 06 Aug 2020
University Hospital Zurich - Department of Dermatology, University Hospital Zurich - Department of Dermatology, University of Zurich - Department of Quantitative Biomedicine, University Hospital Zurich - Department of Dermatology, ETH Zürich - Department of Biosystems Science and Engineering, University Hospital Zurich - Department of Dermatology, ETH Zürich - Department of Biosystems Science and Engineering, University of Zurich - Department of Quantitative Biomedicine, University Hospital Zurich - Department of Dermatology and University Hospital Zurich - Department of Dermatology
Downloads 38 (1,222,651)

Abstract:

Loading...

Oncolytic virotherapy, non-specific cell infection, single-cell RNA sequencing, single cell immune repertoire profiling, T-VEC induced innate and adaptive immunity, primary cutaneous B-cell lymphoma

4.

Efficacy of Immune Checkpoint Inhibitors in Advanced Mucosal Melanoma: A Systematic Review and Meta-Analysis

Number of pages: 31 Posted: 27 Jan 2025
The Kinghorn Cancer Centre, Royal North Shore Hospital, The Kinghorn Cancer Centre, The Kinghorn Cancer Centre, University Hospital Zurich, University Hospital Zurich - Department of Dermatology, The Kinghorn Cancer Centre and The Kinghorn Cancer Centre
Downloads 37 (1,222,651)

Abstract:

Loading...

Meta-analysis, mucosal melanoma, Immune checkpoint inhibitor, survival benchmarks

5.

Clock-Like Mutation Signature May Be Prognostic for Worse Survival than Signatures of UV Damage in Cutaneous Melanoma

Number of pages: 20 Posted: 18 Apr 2023
University Hospital Zurich, University Hospital Zurich - Department of Dermatology, University Hospital Zurich - Department of Dermatology, University Hospital Zurich, University Hospital Zurich, University Hospital Zurich, University Hospital Zurich - Department of Dermatology and University Hospital Zurich - Department of Dermatology
Downloads 37 (1,222,651)

Abstract:

Loading...

clock-like signature, UV signature, COSMIC, mutation profiling, rapid progression